Tri Locum Partners LP’s Teva Pharmaceutical Inds Ltd Position
Does Tri Locum Partners LP own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 1.02M shares worth $31M (+4.32% of its 13F portfolio) as of Q1 2026, down from 1.44M shares the prior filed quarter.
Position Value
$31M
Q1 2026
Shares
1.02M
% of Portfolio
+4.32%
Quarters Held
13
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.02M | $31M | +4.32% |
| Q4 2025 | 1.44M | $45M | +5.82% |
| Q2 2025 | 2.05M | $34M | +10.41% |
| Q1 2025 | 1.06M | $16M | +8.37% |
| Q4 2024 | 2.42M | $53M | +11.06% |
| Q3 2024 | 2.76M | $50M | +11.90% |
| Q2 2024 | 2.55M | $41M | +10.48% |
| Q1 2024 | 2.22M | $31M | +10.84% |
| Q4 2023 | 1.79M | $19M | +8.56% |
| Q3 2023 | 2.63M | $27M | +8.59% |
| Q2 2023 | 1.11M | $8M | +3.09% |
| Q1 2023 | 1.01M | $9M | +2.73% |
| Q3 2022 | 683.6K | $6M | +1.51% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of TEVA.